SOPRANO: Macitentan in pulmonary hypertension post left ventricular assist device implantation. A prospective multi-center double-blind randomized placebo-controlled parallel group study to assess the efficacy and safety of macitentan in patients with pulmonary hypertension after left ventricular assist device implantation (Protocol AC-055-205)



Study Overview

The purpose of this study is to evaluate the effect of macitentan (study drug) on the function of the heart and on the pressure in the pulmonary arteries after LVAD implantation.


Study Description

The purpose of this study is to evaluate the effect of macitentan (study drug) on the function of the heart and on the pressure in the pulmonary arteries after LVAD implantation.

Additional Information:

Participants will be compensated for their participation.



Research Study Identifier: TX7537
ClinicalTrials.gov Identifier: NCT1510320657
Principal Investigator: I-Wen Wang, MD


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.